NCT03505710 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 41
- group Id
- BG002
- value
- 91
- group Id
- BG003
- value
- 181
- units
- Participants
- groups
- description
- Participants with HER2-overexpressing(immunohistochemistry \[IHC\] 3+ or IHC 2+), unresectable and/or metastatic NSCLC adenocarcinoma who received 6.4 mg/kg trastuzumab deruxtecan (DS-8201a). Trastuzumab deruxtecan: Antibody component covalently conjugated to a drug component, prepared by dilution based on body weight for intravenous (IV) infusion.
- id
- BG000
- title
- Cohort 1: HER2 Overexpressing
- description
- Participants with HER2-overexpressing (immunohistochemistry \[IHC\] 3+ or IHC 2+), unresectable and/or metastatic NSCLC adenocarcinoma who received 5.4 mg/kg trastuzumab deruxtecan (DS-8201a). Trastuzumab deruxtecan: Antibody component covalently conjugated to a drug component, prepared by dilution based on body weight for intravenous (IV) infusion.
- id
- BG001
- title
- Cohort 1a: HER2 Overexpressing
- description
- Participants with HER2-mutated, unresectable and/or metastatic NSCLC to who received 6.4 mg/kg trastuzumab deruxtecan (DS-8201a). Trastuzumab deruxtecan: Antibody component covalently conjugated to a drug component, prepared by dilution based on body weight for intravenous (IV) infusion.
- id
- BG002
- title
- Cohort 2: HER2 Mutated
- description
- Total of all reporting groups
- id
- BG003
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- <=18 years
- measurements
- group Id
- BG000
- value
- 27
- group Id
- BG001
- value
- 27
- group Id
- BG002
- value
- 55
- group Id
- BG003
- value
- 109
- title
- Between 18 and 65 years
- measurements
- group Id
- BG000
- value
- 22
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 36
- group Id
- BG003
- value
- 72
- title
- >=65 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Categorical
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9.58
- value
- 62.2
- group Id
- BG001
- spread
- 10.22
- value
- 60.3
- group Id
- BG002
- spread
- 11.94
- value
- 60.3
- group Id
- BG003
- spread
- 10.94
- value
- 60.8
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 19
- group Id
- BG001
- value
- 19
- group Id
- BG002
- value
- 60
- group Id
- BG003
- value
- 98
- title
- Female
- measurements
- group Id
- BG000
- value
- 30
- group Id
- BG001
- value
- 22
- group Id
- BG002
- value
- 31
- group Id
- BG003
- value
- 83
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 13
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 31
- group Id
- BG003
- value
- 48
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 7
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 31
- group Id
- BG001
- value
- 31
- group Id
- BG002
- value
- 40
- group Id
- BG003
- value
- 102
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 19
- group Id
- BG003
- value
- 23
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 10
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 13
- group Id
- BG003
- value
- 31
- title
- Netherlands
- categories
- measurements
- group Id
- BG000
- value
- 19
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 35
- group Id
- BG003
- value
- 67
- title
- United States
- categories
- measurements
- group Id
- BG000
- value
- 12
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 23
- group Id
- BG003
- value
- 38
- title
- Japan
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 15
- group Id
- BG003
- value
- 18
- title
- France
- categories
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 5
- group Id
- BG003
- value
- 27
- title
- Spain
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
- population Description
- Baseline characteristics were assessed using the Safety Analysis Set.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 49
- group Id
- BG001
- value
- 41
- group Id
- BG002
- value
- 91
- group Id
- BG003
- value
- 181
- units
- Participants
- groups
- description
- Participants with HER2-overexpressing(immunohistochemistry \[IHC\] 3+ or IHC 2+), unresectable and/or metastatic NSCLC adenocarcinoma who received 6.4 mg/kg trastuzumab deruxtecan (DS-8201a). Trastuzumab deruxtecan: Antibody component covalently conjugated to a drug component, prepared by dilution based on body weight for intravenous (IV) infusion.
- id
- BG000
- title
- Cohort 1: HER2 Overexpressing
- description
- Participants with HER2-overexpressing (immunohistochemistry \[IHC\] 3+ or IHC 2+), unresectable and/or metastatic NSCLC adenocarcinoma who received 5.4 mg/kg trastuzumab deruxtecan (DS-8201a). Trastuzumab deruxtecan: Antibody component covalently conjugated to a drug component, prepared by dilution based on body weight for intravenous (IV) infusion.
- id
- BG001
- title
- Cohort 1a: HER2 Overexpressing
- description
- Participants with HER2-mutated, unresectable and/or metastatic NSCLC to who received 6.4 mg/kg trastuzumab deruxtecan (DS-8201a). Trastuzumab deruxtecan: Antibody component covalently conjugated to a drug component, prepared by dilution based on body weight for intravenous (IV) infusion.
- id
- BG002
- title
- Cohort 2: HER2 Mutated
- description
- Total of all reporting groups
- id
- BG003
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- <=18 years
- measurements
- group Id
- BG000
- value
- 27
- group Id
- BG001
- value
- 27
- group Id
- BG002
- value
- 55
- group Id
- BG003
- value
- 109
- title
- Between 18 and 65 years
- measurements
- group Id
- BG000
- value
- 22
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 36
- group Id
- BG003
- value
- 72
- title
- >=65 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Categorical
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9.58
- value
- 62.2
- group Id
- BG001
- spread
- 10.22
- value
- 60.3
- group Id
- BG002
- spread
- 11.94
- value
- 60.3
- group Id
- BG003
- spread
- 10.94
- value
- 60.8
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 19
- group Id
- BG001
- value
- 19
- group Id
- BG002
- value
- 60
- group Id
- BG003
- value
- 98
- title
- Female
- measurements
- group Id
- BG000
- value
- 30
- group Id
- BG001
- value
- 22
- group Id
- BG002
- value
- 31
- group Id
- BG003
- value
- 83
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 13
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 31
- group Id
- BG003
- value
- 48
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 7
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 31
- group Id
- BG001
- value
- 31
- group Id
- BG002
- value
- 40
- group Id
- BG003
- value
- 102
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 19
- group Id
- BG003
- value
- 23
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 10
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 13
- group Id
- BG003
- value
- 31
- title
- Netherlands
- categories
- measurements
- group Id
- BG000
- value
- 19
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 35
- group Id
- BG003
- value
- 67
- title
- United States
- categories
- measurements
- group Id
- BG000
- value
- 12
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 23
- group Id
- BG003
- value
- 38
- title
- Japan
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 15
- group Id
- BG003
- value
- 18
- title
- France
- categories
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 5
- group Id
- BG003
- value
- 27
- title
- Spain
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
- population Description
- Baseline characteristics were assessed using the Safety Analysis Set.
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Independent clinical review pending · Not medical advice
Triangle